Immunochemical analysis of the tumor with Ki-67 antibody revealed that although CTX treatment alone could attenuate Ki-67 expression, the percentage of Ki-67 positive staining significantly decreased in the combined therapy of CTX with VNP-shABCB5 (Figure 5A, 5B). This evidence concerns the gene MKI67 and neoplasm.